TrialAntimicrobial agents and chemotherapy2005

In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.

Amy K Patick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.